AGE-RELATED MACULAR DEGENERATION
Clinical trials for AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug tiespectus takes on standard treatment for wet AMD
Disease control Not yet recruitingThis study tests a new medicine called tiespectus (also known as MK-8748 or EYE201) against the standard treatment aflibercept for wet age-related macular degeneration (AMD), a leading cause of vision loss. About 960 people with untreated wet AMD will receive injections into the …
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Elderly AMD patients to test Easy-to-Use home vision tracker
Knowledge-focused Not yet recruitingThis study looks at how willing and able older adults with wet age-related macular degeneration (AMD) are to use a new web-based system that tracks their eye movements to monitor vision at home. The system is designed to be simple and easy to use, even for those with low vision o…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:08 UTC